Suppr超能文献

仿生细胞膜在癌症免疫治疗中的最新进展

Recent Progress of Bioinspired Cell Membrane in Cancer Immunotherapy.

作者信息

Zhang Min, Wang Yuanhang, Song Zhiyuan, Lu Yimeng, Zhao Houyu, Wang Yihan, Lu Ping, Liu Yanting

机构信息

Department of Oncology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China.

Department of Ultrasound Medicine, The First Affiliated Hospital of Henan University, Kaifeng, China.

出版信息

Clin Med Insights Oncol. 2024 Apr 20;18:11795549241236896. doi: 10.1177/11795549241236896. eCollection 2024.

Abstract

By modifying immune cells, immunotherapy can activate immune response to establish long-term immune memory and prevent tumor recurrence. However, their effectiveness is largely constricted by the poor immunogenicity, immune escape, and immune tolerance of the tumor. This is related to the characteristics of the tumor itself, such as genome instability and mutation. The combination of various nanocarriers with tumor immunotherapy is beneficial for overcoming the shortcomings of traditional immunotherapy. Nanocarriers coated by cell membranes can extend blood circulation time, improve ability to evade immune clearance, and enhance targeting, thus significantly enhancing the efficacy of immunotherapy and showing great potential in tumor immunotherapy. This article reviews the application research progress of different types of cell membrane-modified nanocarriers in tumor immunotherapy, immunotherapy combination therapy, and tumor vaccines, and provides prospects for future research.

摘要

通过修饰免疫细胞,免疫疗法可以激活免疫反应以建立长期免疫记忆并预防肿瘤复发。然而,它们的有效性在很大程度上受到肿瘤免疫原性差、免疫逃逸和免疫耐受的限制。这与肿瘤本身的特征有关,如基因组不稳定性和突变。各种纳米载体与肿瘤免疫疗法的结合有利于克服传统免疫疗法的缺点。细胞膜包覆的纳米载体可以延长血液循环时间,提高逃避免疫清除的能力,并增强靶向性,从而显著提高免疫疗法的疗效,并在肿瘤免疫疗法中显示出巨大潜力。本文综述了不同类型细胞膜修饰纳米载体在肿瘤免疫疗法、免疫疗法联合治疗和肿瘤疫苗中的应用研究进展,并对未来研究进行了展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8f5/11032066/0612441e305c/10.1177_11795549241236896-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验